Sucrase-isomaltase deficiency, congenital
|
0.790 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malabsorption Syndrome
|
0.130 |
Biomarker
|
group |
HPO |
|
|
|
Diarrhea
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nephrolithiasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malabsorption, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malabsorption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of metabolism/homeostasis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein.
|
60470 |
1976 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein.
|
60470 |
1976 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state.
|
361294 |
1978 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state.
|
361294 |
1978 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase.
|
388444 |
1979 |
Generalized glycogen storage disease of infants
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase.
|
388444 |
1979 |
Cystic Fibrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, alpha-glucosidase levels in cystic fibrosis patients correlated with the degree of clinical impairment as measured by the Schwachman score.
|
110502 |
1979 |
Muscular Dystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
It remains unknown whether or not the enzyme deficiency in homozygotes for isozyme 2 of acid alpha-glucosidase will be sufficient to cause glycogen accumulation and lead to the development of muscular dystrophy-like disease later in life.
|
6401921 |
1983 |
Glycogen storage disease type II
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Double immunodiffusion studies showed the presence of catalytically inactive acid alpha-glucosidase enzyme protein in canine GSD II.
|
6391168 |
1984 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
Demonstration of acid alpha-glucosidase in different types of Pompe disease by use of an immunochemical method.
|
6442343 |
1985 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells.
|
3891151 |
1985 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells.
|
3891151 |
1985 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
Demonstration of acid alpha-glucosidase in different types of Pompe disease by use of an immunochemical method.
|
6442343 |
1985 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic deficiency of acid alpha-glucosidase results in glycogen-storage disease type II, encompassing a spectrum of disorders of varying severity.
|
3540946 |
1986 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies.
|
3098466 |
1986 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies.
|
3098466 |
1986 |
Generalized glycogen storage disease of infants
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic deficiency of acid alpha-glucosidase results in glycogen-storage disease type II, encompassing a spectrum of disorders of varying severity.
|
3540946 |
1986 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
Total RNA from a patient with the adult form of glycogenosis type II is not able to direct the synthesis of normal amounts of alpha-glucosidase in vitro.
|
3315002 |
1987 |